State Street SPDR S&P Pharmaceuticals ETF XPH
65.36 USD -1.47 (-2.20%)
Regular-session close
65.36 0.00 0.00%
After hours · Nov 16, 4:00 PM ET
65.22 Day range 67.14
50.95 52-week range 74.35
- YTD
- +16.69%
- 1 year
- +28.76%
News
fool.com Which Healthcare ETF Is the Better Buy: State Street's Pharma Fund XPH or iShares' Biotech Fund IBB? State Street SPDR S&P Pharmaceuticals ETF has a lower expense ratio and a higher trailing dividend yield. iShares Biotechnology ETF is significantly larger by assets under management.
fool.com Which Healthcare ETF Is Best for the Long Term: State Street’s XPH or Invesco’s PBE? Lower fees and a steadier beta set one healthcare ETF apart, while the rival fund's richer dividend could sway income-focused investors.
fool.com Drug Makers or Biotech Bets: Which ETF Is the Better Buy, State Street’s XPH or First Trust’s FBT? One fund holds about 60 drug companies at a lower fee. The other holds 30 biotech names and has a stronger long-term record. Either way, expect some volatility.
